- Home
- NBY vs ADIL Comparison
NBY vs ADIL Comparison
Compare NBY & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- ADIL
- Stock Information
- Founded
- NBY 2000
- ADIL 2010
- Country
- NBY United States
- ADIL United States
- Employees
- NBY N/A
- ADIL N/A
- Industry
- NBY
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- NBY
- ADIL Health Care
- Exchange
- NBY Nasdaq
- ADIL Nasdaq
- Market Cap
- NBY 3.5M
- ADIL 3.9M
- IPO Year
- NBY 2007
- ADIL 2018
- Fundamental
- Price
- NBY $0.60
- ADIL $0.34
- Analyst Decision
- NBY Strong Buy
- ADIL Strong Buy
- Analyst Count
- NBY 1
- ADIL 1
- Target Price
- NBY $0.85
- ADIL $8.00
- AVG Volume (30 Days)
- NBY 32.1K
- ADIL 22.2M
- Earning Date
- NBY 08-12-2025
- ADIL 08-12-2025
- Dividend Yield
- NBY N/A
- ADIL N/A
- EPS Growth
- NBY N/A
- ADIL N/A
- EPS
- NBY 0.57
- ADIL N/A
- Revenue
- NBY $9,781,000.00
- ADIL N/A
- Revenue This Year
- NBY $23.91
- ADIL N/A
- Revenue Next Year
- NBY $32.05
- ADIL N/A
- P/E Ratio
- NBY $1.33
- ADIL N/A
- Revenue Growth
- NBY 20.52
- ADIL N/A
- 52 Week Low
- NBY $0.36
- ADIL $0.22
- 52 Week High
- NBY $2.47
- ADIL $3.00
- Technical
- Relative Strength Index (RSI)
- NBY 53.58
- ADIL 50.21
- Support Level
- NBY $0.56
- ADIL $0.22
- Resistance Level
- NBY $0.64
- ADIL $0.27
- Average True Range (ATR)
- NBY 0.03
- ADIL 0.08
- MACD
- NBY -0.00
- ADIL -0.01
- Stochastic Oscillator
- NBY 44.44
- ADIL 53.15
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.